Retro Biosciences is raising $1 billion, with the ultimate goal of using its customized AI to extend human lifespan by 10 ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
However, AI agents like Operator also present new safety and security risks, given the potential for AI to make mistakes or be misused by bad actors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback